Reducing Drug Prices for Seniors Act.
Sponsored By: Senator Rosen, Jacky [D-NV]
Introduced
Summary
Would base Medicare Part D coinsurance on a drug's negotiated net price rather than its list price. It ties patient cost sharing to the plan's negotiated price after manufacturer concessions, using the prior year's Detailed DIR Report to set that net price for many formulary drugs within the deductible-to-out-of-pocket band.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
New Medicare drug coinsurance rule
This bill would require Medicare Part D coinsurance to be based on a drug's net price when that net price is lower than the list price. It would apply for plan years beginning on January 1, 2026. It would only help drugs on your plan's formulary that use coinsurance, not copayments. It would only apply to costs above your annual deductible and below your annual out-of-pocket limit. The bill would use the plan's Detailed DIR Report from the previous plan year to set the net price. It would not apply to drugs listed in paragraphs (8) or (9).
Sponsors & CoSponsors
Sponsor
Rosen, Jacky [D-NV]
NV • D
Cosponsors
Sen. Cornyn, John [R-TX]
TX • R
Sponsored 7/31/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov